Nutrients (Jul 2022)

Postoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial

  • Jorge Alejandro Benavides-Buleje,
  • Pedro Vicente Fernández-Fernández,
  • Elena Ruiz-Úcar,
  • Amparo Solana-Bueno,
  • Pedro Antonio Parra-Baños,
  • Beatriz Martínez-Torres,
  • Roberto Lozoya-Trujillo,
  • María Dolores Ruiz-Carmona,
  • Marina Alarcón-Iranzo,
  • Lorena Rentero-Redondo,
  • Emilio Peña-Ros,
  • José Manuel Muñoz-Camarena,
  • Milagros Carrasco-Prats,
  • María Ramírez-Faraco,
  • Paloma Portillo-Ortega,
  • Antonio Albarracín-Marín-Blázquez

DOI
https://doi.org/10.3390/nu14153062
Journal volume & issue
Vol. 14, no. 15
p. 3062

Abstract

Read online

(1) Background: For normo-nourished colorectal cancer patients, the need for immunonutrients after elective surgery is not known. (2) Methods: Multicenter, randomized, double-blind, phase III clinical trial comparing the postoperative diet with 200 mL oligomeric hyperproteic normocaloric (OHN; experimental arm) supplement vs. 200 mL immunonutritional (IN) (active comparator) supplement twice a day for five days in 151 normo-nourished adult colorectal-resection patients following the multimodal rehabilitation ERAS protocol. The proportions of patients with complications (primary outcome) and those who were readmitted, hospitalized for p = 0.328). No significant differences were found for the rest of the variables. (4) Conclusions: IN supplement may not be necessary for the postoperative recovery of colorectal cancer patients under the ERAS regimen and with normal nutritional status at the time of surgery.

Keywords